JUPITER LIFE LINE HOSP L Latest Share Price (JLHL)
TODAY IN ONE LINE
JLHL slipped 0.7% on above-average volume (5.2x avg), in line with Nifty's -0.3% move, supported by recent strong earnings.
With a market cap of ₹9,144.82 Cr., it trades at a P/E of 49.11. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
JUPITER LIFE LINE HOSP L flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 12.0% YoY
- ●Healthy Operating MarginsOPM is structurally strong at 19.5%
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
No red flags identified
Latest JUPITER LIFE LINE HOSP L News
What changed recently?
Recent events, corporate actions, and announcements.
JUPITER LIFE LINE HOSP L valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for JUPITER LIFE LINE HOSP L, framed against the sector median so the premium or discount is obvious at a glance.
JUPITER LIFE LINE HOSP L trades at a P/E of 49.11× and P/B of 5.92×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
JUPITER LIFE LINE HOSP L technical analysis: indicators, pivots and CPR.
Latest RSI, MACD and moving-average signals plus the latest pivot and Central Pivot Range levels for JUPITER LIFE LINE HOSP L — derived from the latest tape, not yesterday's close.
JUPITER LIFE LINE HOSP L last traded at ₹279.15 with an intraday range of ₹277.3–₹285.05 — latest indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Last: ₹279.15| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 299.20 | +20.05 | +7.18% |
| R3 | 291.45 | +12.30 | +4.41% |
| R2 | 288.25 | +9.10 | +3.26% |
| R1 | 283.70 | +4.55 | +1.63% |
| PIVOT | 280.50 | 1.35 | 0.48% |
| CURRENT | 279.15 | — | — |
| S1 | 275.95 | -3.20 | -1.15% |
| S2 | 272.75 | -6.40 | -2.29% |
| S3 | 268.20 | -10.95 | -3.92% |
| S4 | 260.45 | -18.70 | -6.70% |
JLHL is trading Below CPR, indicating Bearishness
CPR is Average
Day's range: ₹277.55–₹279.8
Trading Inside opening range
JUPITER LIFE LINE HOSP L financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for JUPITER LIFE LINE HOSP L — consolidated or standalone — with margins, YoY growth and key ratios inline.
JUPITER LIFE LINE HOSP L reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹9,144.82 Cr. and reported EPS of ₹1.14.
| Metric | Mar 2025 | Mar 2026 |
|---|---|---|
| Revenue from Operations | 1,262 | 1,500 ▲ 18.9% |
| Sales Growth YoY %Derived | 17.96% | 18.88% |
| Other Income | 29 | 42 ▲ 47.8% |
| Total Income | 1,290 | 1,542 ▲ 19.5% |
| 230 | 287 ▲ 24.8% | |
| Gross ProfitDerived | 1,031 | 1,213 ▲ 17.6% |
| Gross Margin %Derived | 81.76% | 80.85% |
| 735 | 869 ▲ 18.3% | |
| EBITDA (Operating Profit)Derived | 297 | 343 ▲ 15.7% |
| OPM %Derived | 23.51% | 22.89% |
| 68 | 120 ▲ 78.1% | |
| Profit Before Tax (PBT) | 258 | 265 ▲ 3.0% |
| 64 | 66 ▲ 3.2% | |
| Effective Tax %Derived | 24.91% | 24.97% |
| Total Profit for Period | 194 | 199 ▲ 2.9% |
| Less: Non-controlling Interests | 0 | 0 ▼ 40.3% |
| Net Profit (Owner's PAT)Derived | 193 | 199 ▲ 2.9% |
| Net Profit Margin %Derived | 15.31% | 13.26% |
| PAT Growth YoY %Derived | 9.39% | 2.95% |
| Earnings Per Share (EPS ₹) | 5.89 | 6.07 ▲ 3.1% |
| Diluted Shares Outstanding (Cr) | 33 | 33 ▲ 0.0% |
| Other Comprehensive Income (Net of Tax) | -1 | -4 ▼ 281.7% |
| Total Expenses (incl. D&A & Interest) | 1,033 | 1,277 ▲ 23.7% |
| Material Cost % of RevenueDerived | — | — |
| Employee Cost % of RevenueDerived | 17.00% | 17.09% |
| Other Cost % of RevenueDerived | 41.24% | 40.87% |
| Interest Coverage (x)Derived | 22.70x | 7.83x |
| Period | Mar 2024 | Mar 2025 | Mar 2026 | Trend |
|---|---|---|---|---|
| Revenue from Operations | 1,070 | 1,262 ▲ 18.0% | 1,500 ▲ 18.9% | |
| Sales Growth YoY %Derived | — | 17.96% | 18.88% | |
| Other Income | 26 | 29 ▲ 10.4% | 42 ▲ 47.8% | |
| Total Income | 1,095 | 1,290 ▲ 17.8% | 1,542 ▲ 19.5% | |
189 | 230 ▲ 21.5% | 287 ▲ 24.8% | ||
| Gross ProfitDerived | 880 | 1,031 ▲ 17.2% | 1,213 ▲ 17.6% | |
| Gross Margin %Derived | 82.28% | 81.76% | 80.85% | |
642 | 735 ▲ 14.5% | 869 ▲ 18.3% | ||
| EBITDA (Operating Profit)Derived | 238 | 297 ▲ 24.5% | 343 ▲ 15.7% | |
| OPM %Derived | 22.27% | 23.51% | 22.89% | |
69 | 68 ▼ 1.7% | 120 ▲ 78.1% | ||
| Profit Before Tax (PBT) | 195 | 258 ▲ 31.9% | 265 ▲ 3.0% | |
19 | 64 ▲ 241.4% | 66 ▲ 3.2% | ||
| Effective Tax %Derived | 9.62% | 24.91% | 24.97% | |
| Total Profit for Period | 177 | 194 ▲ 9.6% | 199 ▲ 2.9% | |
| Less: Non-controlling Interests | — | 0 | 0 ▼ 40.3% | |
| Net Profit (Owner's PAT)Derived | 177 | 193 ▲ 9.4% | 199 ▲ 2.9% | |
| Net Profit Margin %Derived | 16.51% | 15.31% | 13.26% | |
| PAT Growth YoY %Derived | — | 9.39% | 2.95% | |
| Earnings Per Share (EPS ₹) | 5.39 | 5.89 ▲ 9.3% | 6.07 ▲ 3.1% | |
| Diluted Shares Outstanding (Cr) | 33 | 33 ▲ 0.0% | 33 ▲ 0.0% | |
| Other Comprehensive Income (Net of Tax) | 1 | -1 ▼ 194.6% | -4 ▼ 281.7% | |
| Total Expenses (incl. D&A & Interest) | 900 | 1,033 ▲ 14.7% | 1,277 ▲ 23.7% | |
| Material Cost % of RevenueDerived | — | — | — | |
| Employee Cost % of RevenueDerived | 17.76% | 17.00% | 17.09% | |
| Other Cost % of RevenueDerived | 42.26% | 41.24% | 40.87% | |
| Interest Coverage (x)Derived | 7.43x | 22.70x | 7.83x |
JUPITER LIFE LINE HOSP L segment analysis : revenue and profit mix.
Disclosed business segments at JUPITER LIFE LINE HOSP L with their share of revenue and profit, switchable between consolidated and standalone reporting.
JUPITER LIFE LINE HOSP L discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for JUPITER LIFE LINE HOSP L.
Our AI distills the core fundamental drivers supporting JUPITER LIFE LINE HOSP L, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
JUPITER LIFE LINE HOSP L's investment case rests on 0 positive markers and 1 flagged concerns drawn from the latest reported filings.
What you're getting.
No strengths or opportunities on record.
Key Risks.
SWOT generation temporarily unavailable due to model error. The security token included in the request is invalid.
Flip Conditions.
Valuation risk. a P/E above 64 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Watch interest coverage if debt-to-equity climbs above 1.00. Balance sheet risk re-prices growth multiples fast.
Return-quality risk. ROE below 8% would indicate weaker capital compounding.
JUPITER LIFE LINE HOSP L peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — JUPITER LIFE LINE HOSP L is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
JUPITER LIFE LINE HOSP L chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for JUPITER LIFE LINE HOSP L — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
JUPITER LIFE LINE HOSP L delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for JUPITER LIFE LINE HOSP L over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in JUPITER LIFE LINE HOSP L stood at 56.7% of traded volume, against a 20-day average of 52.1%.
JUPITER LIFE LINE HOSP L announcements: results, concalls, ratings, M&A.
Filings JUPITER LIFE LINE HOSP L sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
JUPITER LIFE LINE HOSP L files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 124 documents below.
Analysts/Institutional Investor Meet/Con. Call Updates
Jupiter Life Line Hospitals Limited has informed the Exchange about Transcript
Copy of Newspaper Publication
Jupiter Life Line Hospitals Limited has informed the Exchange about Copy of Newspaper Publication
Analysts/Institutional Investor Meet/Con. Call Updates
Jupiter Life Line Hospitals Limited has informed the Exchange about Link of Recording
General Updates
Intimation under Regulation 30(5) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements Regulations), 2015 (…
Investor Presentation
Jupiter Life Line Hospitals Limited has informed the Exchange about Investor Presentation
Investor decks & rating reports.
JUPITER LIFE LINE HOSP L dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue JUPITER LIFE LINE HOSP L has declared, sequenced by announce and record date.
JUPITER LIFE LINE HOSP L corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About JUPITER LIFE LINE HOSP L: business, sector, key facts.
What JUPITER LIFE LINE HOSP L does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
JUPITER LIFE LINE HOSP L operates in the Hospital industry under the Healthcare sector, listed as NSE: JLHL, BSE: 543980.
Jupiter Life Line Hospitals Limited (JLHL) is a multi-specialty healthcare provider operating in India under the Jupiter brand. Its core business is the delivery of a wide range of medical services across numerous specialties. This comprehensive approach allows them to cater to a diverse patient population requiring various levels of care.
The hospital's services span a considerable spectrum of medical disciplines. These include, but are not limited to, cardiology and cardiac surgery, oncology, orthopedics (including robotic knee replacement and robotic surgery), neurosurgery, gastroenterology, and a comprehensive range of surgical procedures (general, bariatric, minimal access, and HPB surgical gastroenterology). They also offer specialized care in areas such as organ transplantation, interventional radiology, and mental health.
Beyond surgical and procedural interventions, JLHL provides a substantial array of diagnostic and therapeutic services. These include internal medicine, endocrinology and diabetes care, nephrology, neurology, and rheumatology. Support services such as diagnostic imaging, laboratory testing, and rehabilitation are integral components of their holistic patient care model. Additionally, the hospital offers specialized centers, such as breast care, dental care, and a pain clinic.
In addition to its core healthcare operations, JLHL demonstrates diversification through its ownership of a hotel, the Fortune Park Lake City Hotel in Thane. While this venture is distinct from its primary healthcare focus, it potentially contributes to the overall financial stability and operational infrastructure of the company. This diversification strategy may also serve to attract medical tourists or provide convenient accommodation for patients and their families.
Established in 2002 and headquartered in Mumbai, JLHL has positioned itself as a significant player in the Indian healthcare landscape. Its broad service offerings, combined with its multi-specialty approach, aim to provide comprehensive medical care under one roof. The inclusion of the hotel suggests a business model that aims to go beyond pure healthcare provision to create a more integrated patient experience.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- DR AGARWALS HEALTH CARE L (AGARWALEYE) Share PricePeer
- APOLLO HOSPITALS ENTER L (APOLLOHOSP) Share PricePeer
- ARTEMIS MED SERVICE (ARTEMISMED) Share PricePeer
- ASTER DM QUALITY CARE (ASTERDM) Share PricePeer
- FORTIS HEALTHCARE (FORTIS) Share PricePeer
- Stocks near 52-week low (reversal watch)Screener
- Reversal Hunter strategy playbookStrategy
- Other overvalued NSE stocksScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about JUPITER LIFE LINE HOSP L (JLHL).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of JUPITER LIFE LINE HOSP L (JLHL)?
The current share price of JUPITER LIFE LINE HOSP L (JLHL) is ₹279.15. Today, the stock has declined by ₹1.85 (0.66%), trading in a range of ₹277.30 to ₹285.05. The stock opened at ₹277.55 with a trading volume of 78,427 shares.
02Is JUPITER LIFE LINE HOSP L stock a good investment for long-term?
JUPITER LIFE LINE HOSP L can be considered for long-term investment based on several factors. The company has a market capitalization of ₹9,144.82 Cr., P/E ratio of 49.11, ROE of 12.47%, and ROCE of 10.77%. The dividend yield stands at 0.36%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of JUPITER LIFE LINE HOSP L stock?
The 52-week high price of JUPITER LIFE LINE HOSP L (JLHL) is ₹1,625.00, while the 52-week low is ₹279.00. Currently trading at ₹279.15, the stock is 0.05% above its 52-week low and 82.82% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy JUPITER LIFE LINE HOSP L stock at the current price?
Whether to buy JUPITER LIFE LINE HOSP L stock at ₹279.15 depends on multiple factors. The stock is currently trading with a P/E ratio of 49.11 and P/B ratio of 5.92. Today's performance shows a loss of 0.66%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of JUPITER LIFE LINE HOSP L and when is the next dividend?
JUPITER LIFE LINE HOSP L offers a dividend yield of 0.36%, which means for every ₹100 invested at the current price of ₹279.15, you can expect to receive approximately ₹0.36 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of JUPITER LIFE LINE HOSP L?
JUPITER LIFE LINE HOSP L's key financial metrics include: P/E Ratio: 49.11, P/B Ratio: 5.92, ROE: 12.47%, ROCE: 10.77%, Dividend Yield: 0.36%, EPS: ₹1.14, Book Value: ₹47.10, and Debt-to-Equity: 0.33. The company's market cap stands at ₹9,144.82 Cr.. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is JUPITER LIFE LINE HOSP L stock performing today in the market?
JUPITER LIFE LINE HOSP L stock opened at ₹277.55 and is currently trading at ₹279.15, showing a decline of ₹1.85 (0.66%). The intraday high is ₹285.05 and low is ₹277.30. The trading volume stands at 78,427 shares, indicating moderate market participation today.
08What is the P/E ratio of JUPITER LIFE LINE HOSP L and what does it indicate?
JUPITER LIFE LINE HOSP L has a Price-to-Earnings (P/E) ratio of 49.11, which means investors are willing to pay 49.11 for every ₹1 of earnings. With an EPS of ₹1.14, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about JUPITER LIFE LINE HOSP L (JLHL) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.